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Measurement of dissociation rate
of biomolecular complexes using CE
Fluorescence anisotropy (FA), non-equilibrium CE of equilibrium mixtures (NECEEM)
and high-speed CE were evaluated for measuring dissociation kinetics of peptide–
protein binding systems. Fyn-SH3-SH2, a protein construct consisting of the src
homology 2 (SH2) and 3 (SH3) domain of the protein Fyn, and a fluorescein-labeled
phosphopeptide were used as a model system. All three methods gave comparable half-
life of53 s for Fyn-SH3-SH2:peptide complex. Achieving satisfactory results by
NECEEM required columns over 30 cm long. When using Fyn-SH2-SH3 tagged
with glutathione S-transferase (GST) as the binding protein, both FA and NECEEM
assays gave evidence of two complexes forming with the peptide, yet neither method
allowed accurate measurement of dissociation rates for both complexes because of a lack
of resolution. High-speed CE, with a 7 s separation time, enabled separation of both
complexes and allowed determination of dissociation rate of both complexes indepen-
dently. The two complexes had half-lives of 22.072.7 and 58.876.1 s, respectively.
Concentration studies revealed that the GST-Fyn-SH3-SH2 protein formed a dimer so
that complexes had binding ratios of 2:1 (protein-to-peptide ratio) and 2:2. Our results
demonstrate that although all methods are suitable for 1:1 binding systems, high-speed
CE is unique in allowing multiple complexes to be resolved simultaneously. This
property allows determination of binding kinetics of complicated systems and makes the
technique useful for discovering novel affinity interactions.
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1 Introduction
Quantitative measurements of equilibrium and kinetic
constants of non-covalent protein interactions are essential
in understanding cellular signaling. Many protein–protein
interactions, such as those involving src homology 2 (SH2)
domains, have rapid binding kinetics with complex half-life
on the order of seconds, making measurement of kinetic
constants challenging. Traditional biological methods
including gel electrophoresis, filter binding assay and far
Western blot lack the ability to study binding interactions
with rapid kinetics due to their inherent long analysis time.
Surface plasmon resonance (SPR) has been used extensively
for studies of binding kinetics and can be used for
measuring rapid on–off rates [1–3]. Although SPR is a
powerful method, it requires immobilization of one of the
binding partners, which may cause conformational change
of biomolecules. It also does not necessarily allow for
discovery of unexpected binding stoichiometry. Further-
more, lack of multi-analyte capability limits its application in
studying complex samples such as cell lysates. Fluorescence
anisotropy (FA) has also been employed for binding studies
[4, 5]; however, similar to SPR, FA also lacks the ability to
distinguish multiple analytes.
CE has emerged as a powerful method for quantifica-
tion of binding interactions [6–10]. Although typically
used for determining binding constants or relative
affinity, CE can also be used to determine kinetics. One
approach is ACE, wherein ligand is added to the electro-
phoresis buffer and changes in migration time of the
receptor are used to extract binding data. It is also possible
to determine kinetic constants from peak shapes in ACE;
however, this method has not been used extensively,
presumably because a simulation is required and rate
constants can be measured only indirectly [11, 12]. Another
approach, termed non-equilibrium CE of equilibrium
mixtures (NECEEM) [13], separates a ligand–receptor
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to allow some dissociation of the complex. The resulting
distorted peak shape is used to extract dissociation rates.
A similar approach to peak shape analysis combined with
on-column mixing has been used to determine association
rates [14, 15]. Serial sampling and CE analysis of reacting
mixtures has also been used to determine kinetics. This
approach requires that the separation time be short relative
to the half-life of the reaction. With commercial CE instru-
mentation, where separations typically take minutes, this
approach is limited to fairly slow reactions. The emergence
of high-speed CE with flow-gated injection, which allows
separation to be carried out within a few seconds [16–19],
has opened the door to more relevant biochemical time
scales [20].
Although NECEEM and high-speed CE have emerged as
potential methods for monitoring kinetics of interactions,
they have not been directly compared with standard meth-
ods for validation. In this work, we compare these methods
for determining half-lives of complexes to FA using a model
system consisting of the SH2 and SH3 domain of Fyn (Fyn-
SH2-SH3) as the receptor and a fluorescently labeled
phosphopeptide that binds the SH2 domain (Fluor-Fyn
peptide) as the ligand. Fyn is an Src family tyrosine kinase
involved in T-cell signaling, mitogenic signaling and cell
adhesion [21]. Fyn has also been reported to be involved in
Alzheimer’s disease [22]. Therefore, binding to its SH2
domain is involved in several important cell signaling
events and it represents a potential drug target. We find that
all methods give similar dissociation rates under appropriate
conditions. High-speed CE has a unique ability to
distinguish multiple complexes and to detect unexpected
interactions.
2 Materials and methods
2.1 Chemicals
Unless stated otherwise, all chemicals used were purchased
from Sigma-Aldrich (St. Louis, MO, USA). Tris-glycine
buffer (10 ) was purchased from Bio-Rad laboratories
(Hercules, CA, USA). All solutions were prepared with
deionized water from an E-Pure water purification system
(Barnstead International, Dubuque, IA, USA). 5-Carboxy-
fluorescein succinimidyl ester (5-FAM, SE) and rhodamine
110 were purchased from Molecular Probes (Eugene, OR,
USA). Glutathione sepharose 4B was purchased from GE
healthcare (Piscataway, NJ, USA). Bicinchoninic acid (BCA)
protein assay kit was purchased from Pierce Biotechnology
(Rockford, IL, USA). Fluor-Fyn peptide (fluorescein-
EEEEPQpYEEIPIYL) was synthesized and labeled at the
N-terminus by the Protein Core of the Michigan Diabetes
Research and Training Center. Fyn-SH3-SH2 (525–670) was
expressed and purified as a fusion protein with glutathione
S-transferase (GST) as previously described [23]. The GST
tag was incorporated for purification by glutathione–agarose
beads.
2.2 GST cleavage
Cell lysate containing GST-Fyn-SH3-SH2 was incubated
with glutathione sepharose 4B beads for 1 h at 41C on an
end-over-end rotator. The beads were spun down and
washed three times with HBS-E/Triton buffer (20 mM
HEPES, 0.15 M NaCl, 2 mM EDTA and 1% Triton X-100,
pH 7.5) supplemented with benzamidine and phenyl-
methylsulfonyl fluoride followed by two washing steps with
PBST buffer (16 mM Na2HPO4, 4 mM NaH2PO4, 150 mM
NaCl and 1% Triton, pH 7.3). The beads containing fusion
protein were incubated with thrombin in thrombin buffer
(50 mM Tris, 0.15 M NaCl and 2.5 mM CaCl2, pH 8.0) at an
enzyme-to-substrate ratio of 1:3000 for 2 h at room
temperature. The beads were removed by spinning at
500 rpm for 5 min and the supernatant containing the
Fyn-SH3-SH2 was stored at 801C for future experiments.
The concentration of the purified protein was determined by
a BCA protein assay.
2.3 FA experiments
FA measurements were performed on a BMG Labtech
PHERAstar Microplate Reader (BMG Labtech, Offenburg,
Germany). Fluorescence was excited at 48578 nm and
emission collected through a 535715 nm bandpass
filter. Dissociation rates were determined using a competi-
tion experiment. Initially, 95 mL of a mixture containing
of 500 nM protein (Fyn-SH3-SH2 with or without GST)
and 200 nM Fluor-Fyn peptide were added to the sample
well of a 96-well microplate. An aliquot of 5 mL of 1 mM
unlabeled Fyn peptide was carefully added to the side wall of
the well to form a hanging drop due to surface tension. The
dissociation reaction was started by mixing the drop with the
sample using the shaking function of the plate reader. FA
was continuously monitored every 2 s immediately after the
mixing. To determine the complex half-life and dissociation
rate, the FA signal was plotted versus time and the resulting
curve fitted to an exponential decay function using Origin
7.0 (OriginLab, Northampton, MA, USA).
2.4 NECEEM assays
NECEEM assays were performed using a P/ACE MDQ CE
unit (Beckman Coulter, Fullerton, CA, USA) with a
separation cartridge temperature of 251C and samples
stored at 41C. An Ar1 laser providing 5 mW of 488 nm
light was used for LIF detection. Emission was detected
after passing through a 488 nm notch filter and a
520710 nm bandpass filter. Data acquisition (16 Hz)
and control were performed using P/ACE 32 Karat
Software Version 5.0 (Beckman). Unmodified fused-silica
capillaries (Polymicro Technologies, Phoenix, AZ, USA)
with an inner diameter of 50 mm and an outer diameter of
360 mm were used as the separation capillary. The length to
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the detector (Ld) was varied from 10 to 40 cm and applied
electric field (E) was varied from 100 to 600 V/cm for the
evaluation of NECEEM. The electrophoresis buffer was
25 mM Tris, 192 mM glycine with pH 8.5. Samples were
injected for 3, 4 or 5 s at 0.5 psi for an Ld of 20, 30 or 40 cm,
respectively, and 3 s at 0.4 psi for an Ld of 10 cm. At the
beginning of each day, capillary was rinsed sequentially with
0.1 M NaOH, H2O and electrophoresis buffer for 5 min
each. The capillary was rinsed with 0.1 M NaOH and
electrophoresis buffer for 1 min each prior to each injection.
For NECEEM measurements, sample containing 1 mM
Fyn-SH3-SH2 or 2 mM GST-Fyn-SH3-SH2 and 100 nM
Fluor-Fyn peptide was incubated on ice for 5 min before
being assayed. Both protein and peptide were diluted in Tris-
glycine buffer (pH 8.5) from 100 mM stock solutions. The
peak areas and migration times were measured using soft-
ware written in-house [24]. To be able to account for differ-
ences in fluorescence upon binding in calculations, the
fluorescence intensity of 20 nM Fluor-Fyn peptide and 20 nM
Fluor-Fyn peptide with 2 mM of protein (binding is saturated
under this condition) were measured on the plate reader.
2.5 High-speed CE assays
A drawing of the flow-gated high-speed CE–LIF instrument
is shown in Fig. 1. An unmodified fused-silica capillary
(10 mm id, 360 mm od, total length 5 7.5 cm, inlet-to-detector
length 5 3.8 cm) was used as the separation capillary. All
samples were introduced onto the capillary by electrokinetic
injection via a flow-gate interface at 2 kV for 0.5 s
and separated at 15 kV [25, 26]. Tris-glycine buffer was
continuously delivered to the flow gate at a rate of
1.5 mL/min by a Series I HPLC pump (LabAlliance, Fisher
Scientific, Pittsburgh, PA, USA).
For the competition experiment, 1 mM of unlabeled
Fyn peptide was delivered to a pressurized sample
chamber containing 200 mL of 500 nM Fyn-SH3-SH2
(with or without GST), 200 nM Fluor-Fyn peptide and
10 nM rhodamine 110 (internal standard) at a flow rate of
5 mL/s for 2 s by pressure. A 5 2 mm microbar in the
sample vial together with the stir plate underneath allowed
the unlabeled peptide to be rapidly mixed with the protein
and labeled peptide. After the addition of unlabeled peptide,
the sample was delivered to the flow gate at a rate of 0.8 mL/s
by pressure. The total delay time between addition of unla-
beled peptide and collection of the first electropherogram
was 7 s, including sample delivery time, high voltage
ramping time and injection time. Electropherograms were
collected every 7 s for 250 s and normalized complex peak
height (complex peak height divided by peak height of
internal standard) was plotted versus time to extract koff by
fitting the curve to a one-component exponential decay
function.
3 Results and discussion
3.1 FA assays
Initial experiments were aimed at determining the half-life
of the complex of Fyn-SH2-SH3 with Fluor-Fyn peptide
using FA as a standard method. FA increases with the size
of molecule according to the Perrin Equation [27]; hence the
FA for Fluor-Fyn peptide increases when it binds Fyn-SH2-
SH3 due to the significant size difference. Anisotropies for
different fluorescent species, such as bound and free Fluor-
Fyn peptide, are additive so that in a mixture the total
anisotropy is the weighted average of individual species.
Therefore, monitoring changes in the FA of a mixture of
complex and free peptide allows determination of changes
in the amount bound. For kinetics measurements, we
spiked an equilibrated mixture of Fluor-Fyn peptide and
Fyn-SH2-SH3 with an excess of unlabeled Fyn peptide and
monitored the decrease in FA as Fluor-Fyn peptide
dissociated from the complex (see Fig. 2A). Fitting this
curve to a one-component exponential yields a t1/2 of
53.578.1 s (n 5 3) with an average R2 of 0.91.
We repeated this experiment using GST-Fyn-SH2-SH3
as a receptor instead of Fyn-SH2-SH3. This protein
construct yielded a similar decay (Fig. 2B) with t1/2 5
21.271.3 s. Although similar, these data had a relatively
poor fit (R2 5 0.86) by the single exponential decay and were
better fit with a two-component decay (R2 5 0.97) with t1/2 of
3.370.2 s and 59.576.4 s (n 5 3). These results suggested
the potential for multiple complexes being formed in this
solution, a conclusion that was supported by later electro-
phoresis measurements.
3.2 NECEEM assays
We next determined complex half-life by the NECEEM
method. In this method, the ligand that has dissociated
from the complex during the separation is detected as a
bridge between the complex peak and free ligand peak (see
Fig. 3A for an example). As originally described elsewhere
[13, 28, 29], the complex dissociation rate (koff) can beFigure 1. Schematic drawing of the high-speed CE instrument.
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where A2 is the peak area of the complex (corresponding to
the ligand that was bound and stayed bound during the
experiment), A3 is the area under the bridge (corresponding
to the ligand that dissociated during the separation) and tc is
the migration time of the complex (corresponding to the
time allowed for dissociation). This equation does not
account for differences in fluorescence response factor
when the ligand is bound or free (not uncommon and
observed in this case). To account for these differences, we
modified Eq. (1) to
koff ¼




where tp is the migration time of complex, R is the relative
fluorescence response factor of the free peptide and the
complex. R was measured from the ratio of the fluorescence
intensity of the free peptide and the complex as described
in Section 2. The complex half-life was calculated using
t1/2 5 ln2/koff.
Figure 3A illustrates that when using a 30-cm long
capillary with an Ld of 20 cm and applying 400 V/cm electric
field, the separation time was 6 min and the dissociation of
Fyn-SH3-SH2:Fyn-peptide complex was observed. The
complex half-life calculated using Eq. (2) was 101.0743.6 s
(n 5 5), which was significantly higher than that obtained by
the anisotropy measurement. Furthermore, the variance was
unexpectedly large. We considered the possibility that
experimental variables such as electric field, separation time
and column length could influence the result; hence, we
repeated the experiment with Ld varied from 10 to 40 cm
and electric field from 100 to 600 V/cm as summarized in
Fig. 4. (Because of complete dissociation of the complex,
Figure 2. FA measurements for Fluor-Fyn peptide dissociation
from Fyn-SH3-SH2 (A) and GST-Fyn-SH3-SH2 (B). Sample
contained 20 nM Fluor-Fyn peptide, 500 nM Fyn-SH3-SH2 or
GST-Fyn-SH3-SH2 and 50 mM unlabeled Fyn peptide in Tris-
glycine buffer, pH 8.5. Mixing procedures are described in
Section 2 under FA experiments.
Figure 3. NECEEM electropherograms used in determination of
koff for Fyn-SH3-SH2 (A) and GST-Fyn-SH3-SH2 (B). Sample
contained 1 mM Fyn-SH3-SH2 (A) or 2 mM GST-Fyn-SH3-SH2
(B) and 100 nM Fluor-Fyn peptide and 10 nM rhodamine 110.
Areas marked correspond to bound peptide (A2), peptide that
dissociated during the separation (A3) and the peptide that was
free in the sample solution (A1). The inserted panel in (B) shows
enlarged complex peak. Separation conditions and calculations
of koff are described in Section 2 under NECEEM assays.
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t1/2 was not measured at an electric field of 100 V/cm for an
Ld of 30 cm and at both 100 and 200 V/cm for an Ld of
40 cm.) These experiments revealed that at shorter separa-
tion distances (10 and 20 cm), the calculated t1/2 tends to
decrease with electric field and is less reproducible. These
troublesome effects were eliminated when an Ld of 30 or
40 cm was used. Furthermore, at these lengths, the t1/2 was
60 s in good agreement with the 53.5 s measured by FA.
The reason for the discrepancy and poor reproducibility
at shorter columns was not thoroughly investigated. One
possibility would be Joule heating; however, heating would
be expected to decrease half-life with increasing field.
Furthermore, Ohm’s plots demonstrated no evidence of
heating under any of the conditions used. Another possibi-
lity is that adsorption of the complex to the capillary
distorted the complex peak shape; however, it is difficult to
explain as to why this problem would lessen with longer
capillaries. As discussed in Section 3.2, the modified equa-
tion used discounts the possibility of error due to differences
in fluorescence when bound. Injection artifacts, which tend
to distort electropherograms at short times more than
longer ones, may play a role. Regardless of the source of the
problem, the good agreement with FA results suggests that
the NECEEM method yields accurate results; however, when
using NECEEM, it is worthwhile to test the method at
different column lengths and electric fields to ensure accu-
rate and precise results.
We next tested the NECEEM method on the GST-Fyn-
SH3-SH2:Fluor-Fyn peptide complex. A representative
electrophoretic trace from these experiments (Fig. 3B)
indicates the presence of two complexes as close observation
of the complex zone reveals two incompletely resolved peaks
rather than a single peak, thus confirming the conclusion
from the FA experiment. It may be possible to modify the
NECEEM calculation to obtain koff in this situation;
however, such a calculation would be complicated by
incomplete resolution of the complexes and inability to
distinguish peptide released from one complex versus the
other. These results demonstrate that NECEEM is best
suited for 1:1 binding systems.
3.3 High-speed CE assay
Another way of measuring off-rate is to spike unlabeled
peptide into an equilibrated mixture of complex and
monitor the reaction mixture by continuous sampling and
serial injection onto an electrophoresis capillary. Complex
half-life can then be derived from the gradual decay in
complex peak height over time. This method is similar to
the FA method, except that the complex is monitored as a
separated peak rather than by FA. To achieve rapid sampling
after the unlabeled peptide was added, the system shown in
Fig. 1 was used. In this device, the peptide is rapidly mixed
with the reaction mixture while continually pumping the
sample into the flow gate for serial injection onto the CE.
Electropherograms were acquired at 7 s intervals with this
system and the initial electropherogram was collected 7 s
after the initiation of the reaction. This delay is due to the
dead volume of the system and could be reduced with
smaller capillaries.
As shown in Fig. 5A, the complex peak height versus
time can be fit with a one-component exponential decay
function to yield a t1/2 of 48.4711.1 s (n 5 3) for the Fyn-
SH2-SH3:Fluor-Fyn peptide complex in good agreement
that was determined by FA (53.5 s) and NECEEM (60 s). The
RSD of the method is similar to that of the FA method,
likely representing a problem with manual sample addition
and mixing rather than the measurement methods per se,
and worse than that obtained by NECEEM with 30 or 40 cm
capillaries. These results show that on the 1:1 binding
system, all methods give comparable results.
The FA and NECEEM assays suggested that when using
GST-Fyn-SH2-SH3 as the protein, multiple complexes were
formed; therefore, we evaluated this system using rapid CE.
As shown in Fig. 5B, two distinct complexes were detected
unlike the single complex detected with Fyn-SH2-SH3.
Because the complexes were well resolved, it was possible to
monitor their decay independently, allowing determination
that the first complex has a t1/2 of 22.072.7 s (n 5 3) and the
second complex has a t1/2 of 58.876.1 s (n 5 3). The t1/2 of
complex 2 is consistent with the 59.5 s determined by the FA
experiment. However, the CE assay yields a longer t1/2 for
the other complex than the 3 s determined by fitting the FA
decay data to a two-component exponential decay. The CE
measurement is likely to be more reliable because the
complex was completely resolved and detected indepen-
dently. A concern with the CE method is that the dissocia-
tion of the complex during the separation creates
inaccuracies in the measurement; however, this is unlikely
Figure 4. Complex half-life (t1/2) measured by NECEEM at
different electric fields using capillary with different Ld. Sample
contained 1 mM Fyn-SH3-SH2 and 100 nM Fluor-Fyn peptide.
Experiments were performed under an electric field of 600, 400,
300, 200 and 100 V/cm using capillary with an Ld of 10, 20, 30 and
40 cm. Separation conditions and calculations of koff are
described in Section 2 under NECEEM assays.
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because of the short separation time compared with the
measured complex half-lives. For example, for a t1/2 of 22 s,
and a separation time of 3.8 s (migration time of the
complex), only 2% of the complex is expected to dissociate
over the course of separation. Although both FA and
NECEEM gave evidence of two complexes for the GST-Fyn-
SH3-SH2 binding system, only high-speed CE assay allowed
the off-rate of each individual complex to be determined
independently.
3.4 Mechanism of GST-Fyn-SH3-SH2 binding
The finding that two complexes exist for GST-Fyn-SH3-SH2
protein was unexpected because only the SH2 domain is
expected to bind the peptide and the other domains in the
construct are not expected to affect binding. To better
understand this effect, we used the CE method to further
study the complex.
Two other Fyn constructs (GST-Fyn-SH2 and Fyn-SH2-
SH3) were tested against the same peptide probe. Figure 6
shows that when either the SH3 domain or the GST moiety
is absent, only one complex is detected, indicating that both
GST tag and SH3 domain are required to form the two
complexes. Different concentrations of GST-Fyn-SH2
(0.1–2 mM) or Fyn-SH2-SH3 (0.1–2 mM) and the peptide
(50–700 nM) were tested and similar results were obtained,
indicating that dual complexes were not detected at any
protein or peptide concentration (data not shown).
We next examined the concentration dependency of
complex formation. GST-Fyn-SH3-SH2 concentration was
varied from 0.1 to 2 mM while the concentration of Fluor-Fyn
peptide was kept constant at 200 nM. Figure 7A shows that
complex 2 increases when the protein concentration is
increased from 0.1 to 0.5 mM. However, it starts to decrease
as complex 1 emerges and grows with increasing protein
concentration. At a protein concentration of 2 mM, repre-
senting a tenfold excess over peptide, complex 2 is
completely converted to complex 1. When the peptide
concentration is increased from 50 to 700 nM and the
protein concentration is kept constant at 500 nM, complex 1
first increases and then decreases and complex 2 keeps
increasing (see Fig. 7B). Thus, the ratio of the two complex
peaks (complex 1-to-complex 2 ratio) decreases with
increasing peptide concentration.
This concentration dependency suggests the possibility of
two binding sites on the protein, even though the peptide is
supposed to bind only the SH2 domain of the GST-Fyn-SH3-
SH2. Taking into account that both GST and SH3 domain
are required in order to form two complexes in a concentra-
tion-dependent manner, we hypothesize that the GST and
SH3 domain work cooperatively to form a protein dimer that
contains two SH2 domains and therefore is capable of asso-
ciating with two peptide molecules. Dimerization of Fyn-
Figure 5. Competition experiments using high-speed CE for the
determination of t1/2 for Fyn-SH3-SH2 (A) and GST-Fyn-SH3-SH2
(B). Sample contained 500 nM Fyn-SH3-SH2 (A) or GST-Fyn-SH3-
SH2 (B) and 200 nM Fluor-Fyn peptide with 50 mM unlabeled Fyn
peptide added at t 5 0 s. Injections were made every 7 s for 250 s.
Separation conditions are described in Section 2 under high-
speed CE assays. Complex peak height was plotted versus time
and fit to a one-phase exponential decay function. For GST-Fyn-
SH3-SH2 (B), complex 1 (closed squares) and complex 2 (open
circles) were plotted and fit separately. Representative electro-
pherograms for each sample before dissociation are shown.
Figure 6. Comparison of three constructs of Fyn binding to
Fluor-Fyn peptide. Sample contained 500 nM Fyn-SH2-SH3
(trace 1) or GST-Fyn-SH2 (trace 2) or GST-Fyn-SH2-SH3
(trace 3), 200 nM Fluor-Fyn peptide and 10 nM rhodamine 110.
Separation conditions were the same as in Fig. 5.
Electrophoresis 2009, 30, 457–464462 P. Yang et al.
& 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.electrophoresis-journal.com
SH2-SH3 has been reported previously [30]. Direct binding
between purified SH2 and SH3 domain of Fyn was found
and the binding was enhanced by the occupancy of either
SH2 or SH3 domain with phosphotyrosyl or proline-rich
peptide, respectively [30]. In our hands, dimerization occurs
only when GST is present. A second possibility is dimeriza-
tion of GST, which has also been reported previously [31, 32];
however, we neither observed this effect with other GST
fusion proteins previously tested [23] nor did we observe it in
this case without SH3 domain.
Based on this model, GST-Fyn-SH2-SH3 forms a dimer
due to the intermolecular interaction between SH2 and SH3
domains as well as the two GST moieties. The resulting
dimer contains two phosphotyrosyl peptide-binding sites and
thus is capable of associating with two peptide ligands.
Complex 1 and complex 2 correspond to 2:1 complex and 2:2
complex (protein:peptide), respectively. Thus, as increasing
peptide is added, we see initially complex 1 (2 protein to 1
peptide) and then completely complex 2 (2 protein to 2
peptide). Similarly, as increasing protein is added, we observe
a change from the 2:2 to the 2:1 complex. The binding of the
second peptide molecule to the dimer molecule may stabilize
the complex, which explains why the 2:1 complex has a faster
dissociation rate than the 2:2 complex.
3.5 Comparison of FA, NECEEM and high-speed CE
In this study of peptide:protein binding, we observed that the
FA method offers good temporal resolution for monitoring a
dissociation reaction and a simple experimental method
using commercially available instrumentation. The method
was reliable for monitoring the 1:1 binding system; however,
FA is unable to clearly discern the presence of multiple forms
of complexes, which limits its application in the study of
more complicated binding systems or samples in complex
matrices. Although the observation that the dissociation curve
for GST-Fyn-SH3-SH2 is fit better with a two-component
exponential decay function indicates the possibility of two
complexes, the lack of separation capability prevents straight-
forward measurement of half-lives for the two complexes and
the possibility that the existence of one complex might affect
the kinetics of the other is not excluded. Moreover, if the
number of complexes in the system is increased to above two,
the t1/2 measurement by fitting the data into multi-
component exponential function becomes less reliable,
especially when some complexes have similar t1/2.
NECEEM assays allow equilibrium and kinetic constants
to be determined in a single experiment from area of free,
bound and dissociated species. This method uses commercial
instrumentation and had the simplest data analysis.
Furthermore, it was the most reproducible method, which we
attribute to using electrophoresis to initiate the dissociation
rather than spiking and mixing in unlabeled peptide.
However, the requirement of dissociation during separation
presently limits its application to 1:1 binding systems.
For a system containing more than one complex, it will be
difficult to extract binding constants from a single measure-
ment because the dissociation of both complexes contributes
to the area under the bridge between complex and free ligand
and the contribution of each is indistinguishable. Another
issue, addressed in this paper, is that assay reproducibility
and reliability is dependent on the length of the separation
capillary. In addition, other factors such as protein adsorption
could also affect the accuracy of NECEEM measurements and
need to be avoided as much as possible.
High-speed CE is unique among the methods tested in
that it was suitable for both 1:1 and more complicated bind-
ing systems by virtue of resolving the different complexes
allowing them to be detected independently. This allowed
half-life and concentration dependency of the formation for
multiple complexes to be readily detected, helping to discern
the mechanism of binding of Fyn-GST-SH2-SH3 with Fluor-
Fyn peptide. Moreover, because only complex peak height or
area needs to be measured for koff calculation, fluorescence
intensity change upon binding is not an issue and distorted
peaks shapes due to adsorption of protein onto capillary inner
surface can be ignored. The method does not have as good
temporal resolution as the other methods; however, this may
Figure 7. GST-Fyn-SH3-SH2 binding assay using high-speed CE.
(A) Sample contained 0.1–2 mM GST-Fyn-SH3-SH2, 200 nM Fluor-
Fyn peptide and 10 nM rhodamine 110. (B) Sample contained
0.5 mM GST-Fyn-SH3-SH2, 50–700 nM Fluor-Fyn peptide and
10 nM rhodamine 110. Separation conditions were the same as
in Fig. 5.
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be improved with a more sophisticated fluidic system that
minimizes the dead volume between the sample and elec-
trophoresis channel. The main limitation of this method is
that the instrumentation is not commercially available.
4 Concluding remarks
In this work, we have validated the use of NECEEM and
high-speed CE for dissociation kinetics by comparison to
FA. All methods provide comparable results for 1:1 binding
experiments so long as appropriate conditions are used.
High-speed CE is particularly useful for more complex
binding systems because it allows resolution and indepen-
dent monitoring of complexes.
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